Alira Health Welcomes Romain Finas, Vice President, Real-World Evidence

News
Category:
Published on:
July 1, 2020

Alira Health is excited to welcome Romain Finas as our new Vice President, Real-World Evidence. Based in Paris, France, Romain brings deep expertise in real-world data, healthcare workflow optimization, and pharmaceutical beyond-the-pill solutions that improve access to care and cure or life with the disease.

Romain Finas

Romain will lead Alira Health’s Real-World Evidence practice, which spans the entire value chain of data and evidence generation, including required datasets, collecting and sourcing data with adequate robustness for demonstration and acceptability, managing the accessibility process with GDPR compliance, cleaning and harnessing sources of data as devices, Patient Reported Outcome Measures (PROMs), and Electronic Health Records (EMR), and analyzing and developing models to publish outcomes reports.

Romain’s background includes over 17 years of experience in strategy consulting with a specialty in healthcare organizations. He has held positions in operations transformation (bed management emergency, operating rooms) and hospital strategic roadmap design and execution. Over his five years at MSD, he developed multiple programs to drive innovation into practice and assess outcomes with real-life data in oncology, diabetes, and surgery. Romain also worked on diabetes population management tools within the Electronic Health Records (EMR), to identify patients at risk or to acquire an immediate longitudinal view of the patients’ backgrounds, including therapeutic escalation and evolution of conditions surrogates.

Romain has held positions at healthcare and consulting organizations, including MSD, GE Healthcare, and Accenture. He holds a master’s degree in strategy and finance from ESCP Europe and studied at the University of Sankt Gallen (CH).

Related news

M&A
Publications August 3, 2021
What You Should Know Before Choosing a Healthcare Transaction Advisory Firm
What’s most important when selecting a firm for your next transaction? Global experience, staff profiles, technical expertise? To learn more read our latest TAD Infographic.
M&A MedTech Pharma
News April 12, 2021
Alira Health Strengthens its Growth Strategy with a $35M Funding, led by Creadev
Alira Health strengthens its growth strategy with a $35M funding, led by Creadev.
M&A Pharma
News December 20, 2020
We Announce our role as Strategic Advisor to Mérieux Equity Partners and Mérieux Participations 3 for Entering the Capital of CTRS
We are pleased to announce our role as strategic advisor to Mérieux Equity Partners as they join the Series A financing round of Cell-Easy, through Mérieux’s newly established venture fund, OMX.
M&A
News November 29, 2020
We Announce our Role as Strategic Advisor to Benvic in the Acquisition of Luc & Bel
We are proud to announce our role as strategic advisor to Benvic in the acquisition of Luc & Bel.
M&A
Publications November 1, 2020
Five Key Success Factors for Managing Transactions in Full Virtual Mode
It is no secret that the COVID-19 pandemic has presented new challenges for businesses, and virtual has become the ‘new normal’, including for transactions.
M&A MedTech
Publications October 10, 2020
Q3 2020 Medical Device Contract Development and Manufacturing M&A Report
Despite the COVID-19 pandemic, M&A activity in the global CDMO industry has been exceptionally strong in 2020 with a record number of transactions completed during the third quarter alone.
M&A
News September 11, 2020
We Announce our Role as Advisor to Sagard NewGen
We are pleased to announce our role as Advisor to Sagard NewGen for the equity investment in Laboratoires Delbert. This recent capital raise of €40m supports the company’s growth(...)

Our locations around the globe

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.